Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Atherosclerosis|November 16, 2005
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitusA Falco, F Salvati, E Vitacolonna, et al.
Cancer|November 15, 1993
Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multicentric Randomized FONICAP Trial Report. The Italian Lung Cancer Task ForceA Ardizzoni, F Salvati, R Rosso, et al.
American Journal of Human Genetics|April 1, 1992
Origin heterogeneity of Hb Lepore-Boston gene in ItalyG Fioretti, M De Angioletti, F Masciangelo, et al.
Minerva Medica|April 14, 1981
[Transitory bisalbuminemia secondary to pancreatitis with ascitic effusion]F Masciangelo, R Terlizzi, F Salvati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancerU Gatzemeier, J von Pawel, M Gottfried, et al.
Tumori|July 30, 1999
The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: a phase III randomized FONICAP trial. Italian Lung Cancer Task ForceF De Marinis, M Rinaldi, A Ardizzoni, et al.
American Journal of Clinical Oncology|February 22, 2000
Ambamustine in the second-line treatment of patients with small-cell lung cancer: a phase II Fonicap studyA Ardizzoni, G Antonelli, S Ricci, et al.
Physics in Medicine and Biology|November 10, 2022
GPU-accelerated Monte Carlo simulation of electron and photon interactions for radiotherapy applicationsG Franciosini, G Battistoni, A Cerqua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II studyL Crinò, G Scagliotti, M Marangolo, et al.
British Journal of Cancer|July 2, 1998
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP)E Baldini, C Tibaldi, A Ardizzoni, et al.
Pageof 5